Observational studyInternational urology and nephrology2014

Beneficial dose conversion after switching from higher doses of shorter-acting erythropoiesis-stimulating agents to C.E.R.A in CKD patients in clinical practice: MINERVA Study.

Aleix Cases et al.PubMed ↗Publisher ↗

No numbers read from the abstract.